Impact of Corona&#xA0;Virus Disease-19 (COVID-19) pandemic on gastrointestinal disorders

Inflammatory Bowel Disease

Impact of COVID-19 pandemic on the daily management of biotechnological therapy in inflammatory bowel disease patients: Reorganisational response in a high-volume Italian inflammatory bowel disease centre

United European Gastroenterol J.

Scaldaferri F, Pugliese D, Privitera G, Onali S, Lopetuso LR, Rizzatti G, Settanni CR, Pizzoferrato M, Schiavoni E, Turchini L, Amatucci V, Napolitano D, Bernabei T, Mora V, Laterza L, Papa A, Guidi L, Rapaccini GL, Gasbarrini A, Armuzzi A

doi: 10.1177/2050640620929133.

Inflammatory Bowel Disease

Endoscopy in inflammatory bowel diseases during the COVID-19 pandemic and post-pandemic period

Lancet Gastroenterol Hepatol.

Iacucci M, Cannatelli R, Labarile N, Mao R, Panaccione R, Danese S, Kochhar GS, Ghosh S, Shen B

doi: 10.1016/S2468-1253(20)30119-9.

Irritable Bowel Syndrome (IBS) and Chronic Constipation

The Impact of the Coronavirus Disease 2019 (COVID-19) pandemic on Irritable Bowel Syndrome

J Gastroenterol Hepatol

Quek SXZ, Loo EXL, Demutska A, Chua CE, Kew GS, Wong S, Lau HX, Low EXS, Loh TL, Ooi SL, Hung ECW, Rahma MM, Ghoshal UC, Wong SH, Cheung CKY, Syam AF, Tan N, Xiao Y, Liu JS, Fang L, Chen CL, Lee YY, Maralit RM, Kim YS, Oshima T, Miwa H, Pang J, Siah KTH

doi: 10.1111/jgh.15466

Inflammatory Bowel Disease

Clinical trials for inflammatory bowel disease: a global guidance during COVID-19 pandemic

J Crohns Colitis.

Reinisch W, Danese S, Peyrin-Biroulet L, Loftus EV

doi: 10.1093/ecco-jcc/jjaa119.

Inflammatory Bowel Disease

Management of COVID-19 Pandemic in Spanish Inflammatory Bowel Disease Units: Results From a National Survey

Inflamm Bowel Dis.

Martin Arranz E, Suarez Ferrer C, García Ramírez L, Rueda García JL, Sánchez-Azofra M, Poza Cordón J, Noci J, Zabana Y, Barreiro-de Acosta M, Martín-Arranz MD

doi: 10.1093/ibd/izaa142.

Hepatology

Metabolic associated fatty liver disease increases COVID-19 disease severity in non-diabetic patients

J Gastroenterol Hepatol.

Gao F, Zheng KI, Wang XB, Yan HD, Sun QF, Pan KH, Wang TY, Chen YP, George J, Zheng MH

doi: 10.1111/jgh.15112.

Inflammatory Bowel Disease

Best Practice Guidance for Adult Infusion Centres during the COVID-19 Pandemic: Report from the COVID-19 International Organization for the Study of IBD [IOIBD] Task Force

J Crohns Colitis

Dotan I, Panaccione R, Kaplan GG, O'Morain C, Lindsay JO, Abreu MT, IOIBD.

doi: 10.1093/ecco-jcc/jjaa147

Further Publications

Disease Course and Outcomes of COVID-19 Among Hospitalized Patients with Gastrointestinal Manifestations

Clin Gastroenterol Hepatol

Laszkowska M, Faye AS, Kim J, Truong H, Silver ER, Ingram M, May B, Ascherman B, Bartram L, Zucker J, Sobieszczyk ME, Abrams JA, Lebwohl B, Freedberg DE, Hur C

doi: 10.1016/j.cgh.2020.09.037

Gastrointestinal Cancer

Impact of the COVID-19 pandemic on faecal immunochemical test-based colorectal cancer screening programmes in Australia, Canada, and the Netherlands: a comparative modelling study

Lancet Gastroenterol Hepatol

de Jonge L, Worthington J, van Wifferen F, Iragorri N, Peterse EFP, Lew JB, Greuter MJE, Smith HA, Feletto E, Yong JHE, Canfell K, Coupé VMH, Lansdorp-Vogelaar I, COVID-19 and Cancer Global Modelling Consortium working group 2.

doi: 10.1016/S2468-1253(21)00003-0

Gastroenterology

Impact of Corona Virus Disease-19 (COVID-19) pandemic on gastrointestinal disorders

Related content

Impact of COVID-19 pandemic on the daily management of biotechnological therapy in inflammatory bowel disease patients: Reorganisational response in a high-volume Italian inflammatory bowel disease centre

Endoscopy in inflammatory bowel diseases during the COVID-19 pandemic and post-pandemic period

The Impact of the Coronavirus Disease 2019 (COVID-19) pandemic on Irritable Bowel Syndrome

Clinical trials for inflammatory bowel disease: a global guidance during COVID-19 pandemic

Management of COVID-19 Pandemic in Spanish Inflammatory Bowel Disease Units: Results From a National Survey

Metabolic associated fatty liver disease increases COVID-19 disease severity in non-diabetic patients

Best Practice Guidance for Adult Infusion Centres during the COVID-19 Pandemic: Report from the COVID-19 International Organization for the Study of IBD [IOIBD] Task Force

Disease Course and Outcomes of COVID-19 Among Hospitalized Patients with Gastrointestinal Manifestations

Impact of the COVID-19 pandemic on faecal immunochemical test-based colorectal cancer screening programmes in Australia, Canada, and the Netherlands: a comparative modelling study